ATE227980T1 - Zubereitung mit verzögerter freisetzung und deren herstellung - Google Patents

Zubereitung mit verzögerter freisetzung und deren herstellung

Info

Publication number: ATE227980T1
Authority: AT; Austria
Prior art keywords: production; release preparation; sustained release; sustained; dispersing
Prior art date: 1996-03-28

Application number

AT97908520T

Other languages

English (en)

Inventor

Shigeyuki Takada

Tomofumi Kurokawa

Susumu Iwasa

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-28

Filing date

1997-03-27

Publication date

2002-12-15

1997-03-27 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2002-12-15 Application granted granted Critical

2002-12-15 Publication of ATE227980T1 publication Critical patent/ATE227980T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT97908520T 1996-03-28 1997-03-27 Zubereitung mit verzögerter freisetzung und deren herstellung ATE227980T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP7301696		1996-03-28
PCT/JP1997/001041 WO1997035563A2 (en)	1996-03-28	1997-03-27	Sustained-release preparation and its production

Publications (1)

Publication Number	Publication Date
ATE227980T1 true ATE227980T1 (de)	2002-12-15

Family

ID=13506129

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97908520T ATE227980T1 (de)	1996-03-28	1997-03-27	Zubereitung mit verzögerter freisetzung und deren herstellung

Country Status (8)

Country	Link
US (2)	US6190702B1 (de)
EP (1)	EP0889722B1 (de)
AT (1)	ATE227980T1 (de)
AU (1)	AU2043297A (de)
CA (1)	CA2241322C (de)
DE (1)	DE69717263T2 (de)
DK (1)	DK0889722T3 (de)
WO (1)	WO1997035563A2 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2000500744A (ja)	1995-11-09	2000-01-25	マイクロバイオロジカルリサーチオーソリティー	ワクチン接種および遺伝子治療のためのマイクロカプセル化ｄｎａ
US6270795B1 (en)	1995-11-09	2001-08-07	Microbiological Research Authority	Method of making microencapsulated DNA for vaccination and gene therapy
US6287587B2 (en)	1997-07-15	2001-09-11	Takeda Chemical Industries, Ltd.	Process for producing sustained-release preparation by in-water drying
IL136951A0 (en)	1998-01-16	2001-06-14	Takeda Chemical Industries Ltd	Sustained-release composition, method of its production and use thereof
EP1049458B1 (de) *	1998-01-21	2003-03-26	Takeda Chemical Industries, Ltd.	Verfahren zur gerfriertrocknung von präparaten mit verzörgerter wirkstoffabgabe
AU744354B2 (en)	1998-03-20	2002-02-21	Takeda Chemical Industries Ltd.	Sustained-release preparation of physiologically active polypeptide and production thereof
GB9810236D0 (en)	1998-05-13	1998-07-08	Microbiological Res Authority	Improvements relating to encapsulation of bioactive agents
JP2003519651A (ja) *	2000-01-14	2003-06-24	ブラウンユニバーシティリサーチファウンデーション	微紛化凍結乾燥粒子
US7029700B2 (en)	2000-01-14	2006-04-18	Brown University Research Foundation	Micronized freeze-dried particles
ATE328605T1 (de)	2000-03-24	2006-06-15	Genentech Inc	Verwendung von insulin zur behandlung von knorpelkrankheiten
US7488761B2 (en) *	2000-08-07	2009-02-10	Orthogen Llc	Polymer containing calcium sulfate particles for bone augmentation
US20080233165A1 (en) *	2000-08-07	2008-09-25	Biolok International, Inc.	Time release calcium sulfate and growth factor matrix for bone augmentation
US6824822B2 (en) *	2001-08-31	2004-11-30	Alkermes Controlled Therapeutics Inc. Ii	Residual solvent extraction method and microparticles produced thereby
CA2433037C (en)	2000-12-28	2010-12-21	Takeda Chemical Industries, Ltd.	Sustained-release preparation
JP2002265383A (ja) *	2001-03-14	2002-09-18	Mitsubishi Pharma Corp	インターフェロンα注射用液状製剤
WO2002078673A1 (fr) *	2001-03-29	2002-10-10	Takeda Chemical Industries, Ltd.	Procede de production d'un medicament sous forme de granules fins
US20040126900A1 (en) *	2001-04-13	2004-07-01	Barry Stephen E	High affinity peptide- containing nanoparticles
US6887897B2 (en)	2001-07-31	2005-05-03	Mission Pharmacal Company	Calcium glutarate supplement and phosphorus binder
CA2471521C (en) *	2001-12-26	2010-11-02	Takeda Chemical Industries, Ltd.	Novel microsphere and method for production thereof
LT2891666T (lt)	2002-10-16	2017-10-10	Purdue Pharma L.P.	Antikūnai, kurie prisiriša su ląstelėmis susijusį ca 125/o722p ir jų naudojimo būdas
AU2003286472A1 (en)	2002-10-17	2004-05-04	Alkermes Controlled Therapeutics, Inc. Ii	Microencapsulation and sustained release of biologically active polypeptides
US20070219131A1 (en) *	2004-04-15	2007-09-20	Ben-Sasson Shmuel A	Compositions capable of facilitating penetration across a biological barrier
US7456254B2 (en) *	2004-04-15	2008-11-25	Alkermes, Inc.	Polymer-based sustained release device
DK1734971T3 (da) *	2004-04-15	2012-02-13	Alkermes Pharma Ireland Ltd	Indretning på polymerbasis med forsinket frigivelse
US20060110423A1 (en) *	2004-04-15	2006-05-25	Wright Steven G	Polymer-based sustained release device
US8075910B2 (en) *	2004-05-20	2011-12-13	Pbm Pharmaceuticals, Inc.	Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
DE102005017777A1 (de) *	2005-04-13	2006-10-19	Pharmasol Gmbh	Verfahren zur schonenden Herstellung von hochfeinen Partikelsuspensionen
DE502006005846D1 (de) *	2005-04-13	2010-02-25	Abbott Gmbh & Co Kg	Verfahren zur schonenden herstellung hochfeiner partikelsuspensionen und hochfeiner partikel sowie deren verwendung
PT2359808E (pt)	2006-08-09	2013-08-28	Intarcia Therapeutics Inc	Sistemas de entrega osmótica e montagens de pistão
AU2008231093A1 (en) *	2007-03-22	2008-10-02	Alkermes, Inc.	Coacervation process
PL2157967T3 (pl)	2007-04-23	2013-06-28	Intarcia Therapeutics Inc	Formulacje zawiesinowe peptydów insulinotropowych i ich zastosowania
US20080317865A1 (en) *	2007-06-20	2008-12-25	Alkermes, Inc.	Quench liquids and washing systems for production of microparticles
EP2044934A1 (de) *	2007-10-01	2009-04-08	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Dispersion von Poloxamer-Proteinpartikeln, Herstellungsmethoden und Verwendung davon
CA2726861C (en)	2008-02-13	2014-05-27	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
PT2341905T (pt) *	2008-09-04	2020-07-27	Amylin Pharmaceuticals Inc	Formulações de libertação sustentada utilizando transportadores não aquosos
CN102176900B (zh)	2008-09-17	2017-09-26	克艾思马有限公司	药物组合物和相关的给药方法
HUE035862T2 (en)	2009-09-28	2018-05-28	Intarcia Therapeutics Inc	Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MA41462A (fr)	2015-02-03	2021-05-12	Chiasma Inc	Méthode de traitement de maladies
MX2017015504A (es)	2015-06-03	2018-05-15	Intarcia Therapeutics Inc	Sistemas de colocacion y remoción de implante.
CA3024479A1 (en)	2016-05-16	2017-11-23	Intarcia Therapeutics, Inc.	Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
CN110225762A (zh)	2017-01-03	2019-09-10	因塔西亚制药公司	包括glp-1受体激动剂的连续施用和药物的共同施用的方法
WO2018156935A1 (en) *	2017-02-24	2018-08-30	The Regents Of The University Of California	Particle-drop structures and methods for making and using the same
US11141457B1 (en)	2020-12-28	2021-10-12	Amryt Endo, Inc.	Oral octreotide therapy and contraceptive methods

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4774091A (en)	1983-10-14	1988-09-27	Sumitomo Pharmaceuticals Company, Ltd.	Long-term sustained-release preparation
US5385738A (en)	1983-10-14	1995-01-31	Sumitomo Pharmaceuticals Company, Ltd.	Sustained-release injection
US4963367A (en)	1984-04-27	1990-10-16	Medaphore, Inc.	Drug delivery compositions and methods
US4962091A (en)	1986-05-23	1990-10-09	Syntex (U.S.A.) Inc.	Controlled release of macromolecular polypeptides
JP3116311B2 (ja)	1990-06-13	2000-12-11	エーザイ株式会社	マイクロスフィアの製法
NZ240214A (en)	1990-10-16	1993-02-25	Takeda Chemical Industries Ltd	Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
US5288502A (en) *	1991-10-16	1994-02-22	The University Of Texas System	Preparation and uses of multi-phase microspheres
ES2151541T3 (es)	1992-12-02	2001-01-01	Alkermes Inc	Microesferas que contienen hormona del crecimiento de liberacion prolongada.
US5589167A (en)	1993-02-23	1996-12-31	Genentech, Inc.	Excipient stabilization of polypeptides treated with organic solvents
NZ260909A (en) *	1993-07-05	1995-04-27	Takeda Chemical Industries Ltd	Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
DK0724433T3 (da)	1993-10-22	1999-08-30	Genentech Inc	Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje
US6117455A (en) *	1994-09-30	2000-09-12	Takeda Chemical Industries, Ltd.	Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
TW448055B (en) *	1995-09-04	2001-08-01	Takeda Chemical Industries Ltd	Method of production of sustained-release preparation
EP0765660A3 (de) *	1995-09-28	1998-09-23	Takeda Chemical Industries, Ltd.	Mikrokapseln enthaltend 2-Piperazinon-1-essigsäure Verbindungen

1997
- 1997-03-27 CA CA002241322A patent/CA2241322C/en not_active Expired - Fee Related
- 1997-03-27 WO PCT/JP1997/001041 patent/WO1997035563A2/en active IP Right Grant
- 1997-03-27 EP EP97908520A patent/EP0889722B1/de not_active Expired - Lifetime
- 1997-03-27 US US08/849,172 patent/US6190702B1/en not_active Expired - Lifetime
- 1997-03-27 AU AU20432/97A patent/AU2043297A/en not_active Abandoned
- 1997-03-27 DE DE69717263T patent/DE69717263T2/de not_active Expired - Lifetime
- 1997-03-27 DK DK97908520T patent/DK0889722T3/da active
- 1997-03-27 AT AT97908520T patent/ATE227980T1/de not_active IP Right Cessation
2001
- 2001-01-19 US US09/764,052 patent/US20010006678A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0889722A2 (de)	1999-01-13
DE69717263D1 (de)	2003-01-02
DE69717263T2 (de)	2003-07-24
EP0889722B1 (de)	2002-11-20
CA2241322A1 (en)	1997-10-02
US6190702B1 (en)	2001-02-20
DK0889722T3 (da)	2003-02-10
CA2241322C (en)	2009-01-13
US20010006678A1 (en)	2001-07-05
AU2043297A (en)	1997-10-17
WO1997035563A3 (en)	1997-11-20
WO1997035563A2 (en)	1997-10-02

Publication	Publication Date	Title
ATE227980T1 (de)	2002-12-15	Zubereitung mit verzögerter freisetzung und deren herstellung
ATE193649T1 (de)	2000-06-15	Neue stabile galenische formulierungen, die eine säurelabile benzimidazolverbindung enthalten, und herstellungsverfahren
AU2001236905A1 (en)	2001-08-20	Bioadhesive composition
HU9600647D0 (en)	1996-05-28	Phosphono-monoester-nucleinic acids, process for producing them, and their use
DE69613095D1 (de)	2001-07-05	Intelligentes CAD-Verfahren, das Leistungswerte von Produkten miteinbezieht
ATE196457T1 (de)	2000-10-15	Verfahren zur herstellung von halogenierten alkanen
PT709034E (pt)	2002-04-29	Processo para o fabrico de um agente de textura para produtos lacteos
ES2102388T3 (es)	1997-08-01	Polidextrosa modificada y procedimiento para su preparacion.
CA2032278A1 (en)	1991-06-20	Multistep synthesis of hexafluoropropylene
DE69729312D1 (de)	2004-07-01	Mikropartikel mit gesteuerter Freisetzung
AU2503788A (en)	1989-05-25	Process for the production of biodegradable microcapsules of water-soluble peptides and proteins, and microcapsules obtained by this process
BG102623A (en)	1999-03-31	New derivatives of benzoylguanadine, methods for their preparation and application for the manufacture of medicamentous forms
AR013824A1 (es)	2001-01-31	Producto alimenticio expandido para el consumo humano o animal y un procedimiento para su preparacion
EP0162465A3 (de)	1987-02-25	Verbindungen verwendet in Parfüms
EP0425680A4 (en)	1992-07-08	New vitamin b 12? derivative, production thereof, and application thereof
PL325398A1 (en)	1998-07-20	Novel derivatives of carboxylic acids, their production and application
ATE181202T1 (de)	1999-07-15	Formung von frischen käse
FR2760644B1 (fr)	2000-01-28	Composition a base de collagene, son procede de preparation et ses applications
AU7948694A (en)	1995-05-08	Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation
MX9102624A (es)	1992-06-01	Composicion de shampoo acondicionador y proceso para su produccion.
IT1293123B1 (it)	1999-02-11	Metodo per la produzione di manufatti floccati e decorati, attrezzatura per detta produzione e manufatti cosi' realizzati.
NO980095D0 (no)	1998-01-09	Nye quinoxalin- og quinoxalinylalkan-forfonsyrer
RU96118680A (ru)	1997-09-27	Способ производства пищевого продукта
ATE205210T1 (de)	2001-09-15	2-azabicyclo(2.2.1)heptan-derivate, ihre herstellung und ihre anwendung
FI953320L (fi)	1997-01-06	Menetelmä 4-alkyyli-2-hydroksi-3,5-diklooribentseenisulfonihappojen valmistamiseksi

Legal Events

Date	Code	Title	Description
2003-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties